180 related articles for article (PubMed ID: 23320772)
1. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
Pagh A; Vedtofte T; Lynggaard CD; Rubek N; Lonka M; Johansen J; Andersen E; Kristensen CA; von Buchwald C; Andersen M; Godballe C; Overgaard J; Grau C
Acta Oncol; 2013 Feb; 52(2):277-84. PubMed ID: 23320772
[TBL] [Abstract][Full Text] [Related]
2. [Centralized follow-up of patients treated for head and neck cancer].
Grau C; Specht LK; Hansen HS; Overgaard M; Overgaard J
Ugeskr Laeger; 1997 Feb; 159(8):1104-8. PubMed ID: 9072857
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of follow-up activities after curative treatment for head and neck cancer.
Pagh A; Grau C; Overgaard J
Acta Oncol; 2015 May; 54(5):813-9. PubMed ID: 25907822
[TBL] [Abstract][Full Text] [Related]
4. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.
Jensen K; Bonde Jensen A; Grau C
Radiother Oncol; 2006 Mar; 78(3):298-305. PubMed ID: 16524633
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of current regular follow-up policy after treatment for head and neck cancer: Need for individualized and obligatory follow-up strategy.
Jung YH; Song CM; Park JH; Kim H; Cha W; Hah JH; Kwon TK; Kim KH; Sung MW
Head Neck; 2014 May; 36(5):715-21. PubMed ID: 23616261
[TBL] [Abstract][Full Text] [Related]
6. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.
Merkx MA; van Gulick JJ; Marres HA; Kaanders JH; Bruaset I; Verbeek A; de Wilde PC
Head Neck; 2006 Jan; 28(1):1-7. PubMed ID: 16155911
[TBL] [Abstract][Full Text] [Related]
8. The value of routine follow-up in patients treated for carcinoma of the vulva.
Oonk MH; de Hullu JA; Hollema H; Mourits MJ; Pras E; Wymenga AN; van der Zee AG
Cancer; 2003 Dec; 98(12):2624-9. PubMed ID: 14669281
[TBL] [Abstract][Full Text] [Related]
9. 'When will I see you again?' Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients.
Lester SE; Wight RG
Clin Otolaryngol; 2009 Dec; 34(6):546-51. PubMed ID: 20070764
[TBL] [Abstract][Full Text] [Related]
10. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer.
Flynn CJ; Khaouam N; Gardner S; Higgins K; Enepekides D; Balogh J; MacKenzie R; Singh S; Davidson J; Poon I
Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):868-73. PubMed ID: 20650620
[TBL] [Abstract][Full Text] [Related]
11. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
13. Oncologic effectiveness of selective neck dissection in the N0 irradiated neck.
Solares CA; Fritz MA; Esclamado RM
Head Neck; 2005 May; 27(5):415-20. PubMed ID: 15712298
[TBL] [Abstract][Full Text] [Related]
14. Correlation between subjective evaluation of symptoms and objective findings in early recurrent head and neck squamous cell carcinoma.
Nisa L; La Macchia R; Boujelbene N; Sandu K; Khanfir K; Giger R
JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):687-93. PubMed ID: 23788001
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
Busquets JM; García HA; Trinidad-Pinedo J; Baez A
P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
[TBL] [Abstract][Full Text] [Related]
16. Electroporation therapy for head and neck cancer including carotid artery involvement.
Allegretti JP; Panje WR
Laryngoscope; 2001 Jan; 111(1):52-6. PubMed ID: 11192900
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
18. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
[TBL] [Abstract][Full Text] [Related]
19. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
20. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W
Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
